Spotlight
Video

Are There New MPN Therapies in Development to Decrease Fibrosis?

Loading........
Description: “Can we interrupt the fibrotic process?” MPN expert Dr. Srdan Verstovsek of MD Anderson Cancer Center explains PRM-151, and how this anti-fibrotic therapy is being used to improve the quality of life for patients living with a myeloproliferative neoplasm (MPN). Dr. Verstovsek ends this conversation with these words, “With good control….it appears to be making people live longer.”

Get email alerts | http://www.patientpower.inf...

Subscribe on YouTube | http://www.youtube.com/pati...
Like on Facebook | http://www.fb.com/patientpo...
Follow on Twitter | http://www.twitter.com/pati...
Follow on Google+ | http://www.google.com/+pati...
Shared By : P2Professional
Posted on : 02/09/16
Added : 3 years ago